Bluebird BIO Email Format

Biotechnology Research
201-500 employees
Somerville, MA, USA

Bluebird BIO is a commercial-stage biotechnology company developing and delivering genetic therapies for patients with severe rare diseases including sickle cell disease and beta-thalassemia.

Find contacts at Bluebird BIO

Search our verified sources for decision-makers, emails, and titles.

Start searching
VERIFIED BY CLAY

firstinitiallast@bluebirdbio.com

Company Overview

Industry
Biotechnology Research
Founded
1992
Headquarters
Somerville, MA, USA
Revenue
$25M-$50M
FUNDING Stage
Private
Key Executives
David Meek (CEO), Wendy DiCicco (Chief Financial Officer), Thomas Klima (Chief Commercial & Operating Officer)

Tech Stack

Amazon Web Services (AWS)

Cloud

Signup

to know

Signup

to know

Signup

to know

Key Executives

Chief Executive Officer

Find the current person →

Chief Finance Officer

Find the current person →

Chief Operating Officer

Find the current person →

Chief Technology Officer

Find the current person →

Chief Marketing Officer

Find the current person →

Chairman

Find the current person →

4.9/5 on G2
40K+ GTM professionals
SOC 2 Type II certified

Frequently Asked Questions

What is the email format of Bluebird BIO?

Bluebird BIO uses the firstinitiallast format, so Jane Smith would be jsmith@bluebirdbio.com.

What FDA-approved gene therapy products does Bluebird BIO currently offer?

Bluebird BIO has three FDA-approved one-time gene therapies: Lyfgenia for sickle cell disease, Zynteglo for beta-thalassemia, and Skysona for cerebral adrenoleukodystrophy. All three are administered using the patient's own blood stem cells and target the root cause of each disease.

Who is the CEO of Bluebird BIO?

David Meek leads Bluebird BIO as Chief Executive Officer. He brings more than 30 years of global biopharma experience, including prior CEO roles at Mirati Therapeutics, FerGene, and Ipsen.

How can I find and verify a Bluebird BIO contact for outreach?

Bluebird BIO uses the firstinitiallast format at bluebirdbio.com, so you can build addresses directly once you have a name. Tools like Clay can help you enrich a prospect list with verified Bluebird BIO contacts and confirm email addresses before reaching out.

When did Bluebird BIO rebrand and transition to private ownership?

Bluebird BIO was acquired by Carlyle and SK Capital Partners in June 2025 and rebranded as Genetix Biotherapeutics in September 2025, returning to its roots as a company originally founded in 1992 under the Genetix name.

Share Article

Get access to more people and company data using Clay

Leverage the power of 100+ data providers for industry-leading data coverage & quality.

4.9 rating

More Articles